XOPENEX (levalbuterol hydrochloride) Akorn Patent: 6,451,289 Expiration: Mar 21, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post D…
Drug Patent Expirations for the Week of March 21, 2021 Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in France. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical …
Which pharmaceutical companies have the most SPCs in France? Read Post »
This chart shows the drugs with the most patents in Greece. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Greece? …
Which pharmaceutical drugs have the most drug patents in Greece? Read Post »
Annual Drug Patent Expirations for XOPENEX Xopenex is a drug marketed by Akorn and Sunovion and is included in two NDAs. It is available from two suppliers. There are three…
The post New patent expiration for AKORN drug XOPENEX appeared first on DrugPa…
This chart shows the drugs with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Bulgar…
Which pharmaceutical drugs have the most drug patents in Bulgaria? Read Post »
Annual Drug Patent Expirations for CEQUA Cequa is a drug marketed by Sun Pharma Global and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Sun Pharma drug CEQUA appeared first on DrugPatentWatch – Mak…
Annual Drug Patent Expirations for CEQUA Cequa is a drug marketed by Sun Pharma Global and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Sun Pharma drug CEQUA appeared first on DrugPatentWatch – Mak…
Annual Drug Patent Expirations for XEPI Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent for Ferrer Internacional drug XEPI appeared first on Dr…
Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-one…
The post New patent for Teva Pharm drug AIRDUO RESPICLICK ap…
New patent for Teva Pharm drug AIRDUO RESPICLICK Read Post »
Annual Drug Patent Expirations for AIRDUO+DIGIHALER Airduo Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-four…
The post New patent for Teva Pharm drug AIRDUO DIGIHALER appe…
Get new actionable insights and updates from BiotechBlog
